CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended				83 Months Ended
	Mar. 31, 2014		Mar. 31, 2013		Mar. 31, 2014
Revenue	$ 0		$ 0		$ 0
Operating expense
Research and development	107,641	[1]	401,099	[1]	5,952,122	[1]
General & administrative	380,850	[2]	239,811	[2]	9,074,964	[2]
Total operating expense	510,210		655,910		16,228,130
Net operating loss	(510,210)		(655,910)		(16,228,130)
Other income (expense)
Interest income	5,573		124		86,699
Other income	0		0		244,479
Other expense	(239)		(216)		(5,222)
Total Other Income (Expense)	5,334		(92)		325,956
Net Loss	(504,876)		(656,002)		(15,902,174)
Loss per share
Net loss per share, basic and diluted	$ (0.01)		$ (0.01)		$ (0.31)
Basic and diluted weighted average number of common shares outstanding	89,237,872		62,219,050		51,268,122
Related Party
Operating expense
Research and development	$ 21,719	[3]	$ 15,000	[3]	$ 1,201,044	[3]

[1] Research and development expense includes stock option expense of $6,623 and $11,414 for the quarters ending 3/31/2014 and 3/31/2013, respectively; and $462,500 for the period from inception through 3/31/2014. Research and development expense also includes amortization expense of $40,156 for the quarters ending 3/31/2014 and 3/31/2013; and $1,177,515 for the period from inception through 3/31/2014.

[2] General & administrative expense includes stock option expense of $79,655 and $4,605 for the quarters ending 3/31/2014 and 3/31/2013, respectively; and for the period from inception through 3/31/2014, $3,342,011 for stock option and warrant expense and $318,500 in stock for services.

[3] Includes $690,000 technology impairment charge for the period from inception through 3/31/2014.